BRPI0712273A2 - Anticorpos isolados, polipeptídeos imunoglobulinas, anticorpo hepsina, molécula de ácido nucléico, célula hospedeira, linhagem celular, métodos para produzir o anticorpo, para diagnosticar a presença de hepsina, tratar uma doença, para monitorar a doença residual, para detectar o estado da doença, para diagnosticar uma disfunção, composição, arranjo ou chip de proteína e kit - Google Patents
Anticorpos isolados, polipeptídeos imunoglobulinas, anticorpo hepsina, molécula de ácido nucléico, célula hospedeira, linhagem celular, métodos para produzir o anticorpo, para diagnosticar a presença de hepsina, tratar uma doença, para monitorar a doença residual, para detectar o estado da doença, para diagnosticar uma disfunção, composição, arranjo ou chip de proteína e kit Download PDFInfo
- Publication number
- BRPI0712273A2 BRPI0712273A2 BRPI0712273-0A BRPI0712273A BRPI0712273A2 BR PI0712273 A2 BRPI0712273 A2 BR PI0712273A2 BR PI0712273 A BRPI0712273 A BR PI0712273A BR PI0712273 A2 BRPI0712273 A2 BR PI0712273A2
- Authority
- BR
- Brazil
- Prior art keywords
- antibody
- methods
- diagnose
- kit
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
ANTICORPOS ISOLADOS, POLIPEPTÍDEOS IMUNOGLOBULINAS, ANTICORPO HEPSINA, MOLÉCULA DE ÁCIDO NUCLEICO, CÉLULA HOSPEDEIRA, LINHAGEM CELULAR, MÉTODOS PARA PRODUZIR O ANTICORPO, PARA DIAGNOSTICAR A PRESENÇA DE HEPSINA, TRATAR UMA DOENÇA, PARA MONITORAR A DOENÇA RESIDUAL, PARA DETECTAR O ESTADO DA DOENÇA, PARA DIAGNOSTICAR UMA DISFUNÇçO, COMPOSIÇçO, ARRANJO OU CHIP DE PROTEÍNA E KIT <UM>RESUMO<MV> São fornecidos anticorpos monoclonais anti-HEPSINA e métodos para uso dos mesmos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80558906P | 2006-06-22 | 2006-06-22 | |
US60/805,589 | 2006-06-22 | ||
PCT/US2007/071688 WO2007149932A2 (en) | 2006-06-22 | 2007-06-20 | Methods and compositions for targeting hepsin |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0712273A2 true BRPI0712273A2 (pt) | 2012-03-06 |
BRPI0712273A8 BRPI0712273A8 (pt) | 2019-01-22 |
Family
ID=38754528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0712273A BRPI0712273A8 (pt) | 2006-06-22 | 2007-06-20 | anticorpos isolados, polipeptídeos imunoglobulinas, anticorpo hepsina, molécula de ácido nucléico, célula hospedeira, linhagem celular, métodos para produzir o anticorpo, para diagnosticar a presença de hepsina, tratar uma doença, para monitorar a doença residual, para detectar o estado da doença, para diagnosticar uma disfunção, composição, arranjo ou chip de proteína e kit |
Country Status (16)
Country | Link |
---|---|
US (2) | US8124352B2 (pt) |
EP (1) | EP2044124A2 (pt) |
JP (1) | JP2009540835A (pt) |
KR (1) | KR101410195B1 (pt) |
CN (1) | CN101490088B (pt) |
AU (1) | AU2007260950B2 (pt) |
BR (1) | BRPI0712273A8 (pt) |
CA (1) | CA2656168A1 (pt) |
IL (1) | IL195561A (pt) |
MX (1) | MX2008015882A (pt) |
MY (1) | MY150643A (pt) |
NO (1) | NO20090333L (pt) |
NZ (1) | NZ573178A (pt) |
RU (1) | RU2009101813A (pt) |
WO (1) | WO2007149932A2 (pt) |
ZA (1) | ZA200810225B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008522632A (ja) | 2004-12-13 | 2008-07-03 | アレシア・バイオセラピューティクス・インコーポレーテッド | 骨再構築のプロセスに関与するポリヌクレオチド及びポリペプチド配列 |
CN101490088B (zh) | 2006-06-22 | 2015-04-08 | 健泰科生物技术公司 | 用于靶向hepsin的方法和组合物 |
CA2778481A1 (en) | 2009-10-22 | 2011-04-28 | Genentech, Inc. | Anti-hepsin antibodies and methods using same |
MX2012004617A (es) | 2009-10-22 | 2012-05-08 | Genentech Inc | Metodos y composiciones para modular activacion de hepsina de proteina que estimula macrofago. |
ES2581314T3 (es) | 2010-03-02 | 2016-09-05 | Seattle Genetics, Inc. | Métodos de cribado de anticuerpos |
WO2011161189A1 (en) | 2010-06-24 | 2011-12-29 | F. Hoffmann-La Roche Ag | Anti-hepsin antibodies and methods of use |
HUE063461T2 (hu) | 2011-05-27 | 2024-01-28 | Glaxo Group Ltd | BCMA (CD269/TNFRSF17)-kötõ fehérjék |
UA112434C2 (uk) | 2011-05-27 | 2016-09-12 | Ґлаксо Ґруп Лімітед | Антигензв'язувальний білок, який специфічно зв'язується з всма |
WO2017162659A1 (en) | 2016-03-24 | 2017-09-28 | Bayer Pharma Aktiengesellschaft | Intracellular hepsin as therapeutic target for the treatment of cancer with centrosome amplification |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7282198B2 (en) | 1997-03-19 | 2007-10-16 | The University Of Arkansas For Medical Sciences | Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme |
US6268165B1 (en) | 1997-03-19 | 2001-07-31 | The Board Of Trustees Of The University Of Arkansas | Methods for the early diagnosis of ovarian cancer |
US5981830A (en) | 1997-05-30 | 1999-11-09 | Schering Aktiengesellschaft | Knockout mice and their progeny with a disrupted hepsin gene |
EP1252300B1 (en) | 2000-02-03 | 2011-01-19 | Dendreon Corporation | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
US6423543B1 (en) | 2000-12-20 | 2002-07-23 | Isis Pharmaceuticals, Inc. | Antisense modulation of hepsin expression |
EP1425413A2 (en) | 2001-01-23 | 2004-06-09 | Irm, Llc | Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
WO2002064839A2 (en) | 2001-02-14 | 2002-08-22 | Tularik Inc. | Methods for the diagnosis and treatment of tumors employing the hepsin gene |
US6482630B2 (en) | 2001-03-29 | 2002-11-19 | Applera Corporation | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
US7229774B2 (en) | 2001-08-02 | 2007-06-12 | Regents Of The University Of Michigan | Expression profile of prostate cancer |
AU2002335640A1 (en) * | 2001-08-17 | 2003-03-03 | Affymetrix, Inc. | Gleason grade 4/5 prostate cancer genes |
US20040009911A1 (en) | 2002-01-31 | 2004-01-15 | Irm, Llc | Hepsin substrates and prodrugs |
US20040001801A1 (en) | 2002-05-23 | 2004-01-01 | Corvas International, Inc. | Conjugates activated by cell surface proteases and therapeutic uses thereof |
JP3775346B2 (ja) * | 2002-05-29 | 2006-05-17 | 株式会社日立製作所 | テレビ電話システムおよびその端末装置 |
AU2003260316A1 (en) | 2002-07-23 | 2004-02-09 | Bayer Healthcare Ag | Regulation of human hepsin |
US6977170B2 (en) | 2002-09-06 | 2005-12-20 | Applera Corporation | Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof |
EP1558731A4 (en) | 2002-10-04 | 2007-01-10 | Schering Ag | MODIFIED HEPSINE MOLECULES COMPRISING A SUBSTITUTION ACTIVATION SEQUENCE AND USES THEREOF |
KR101222254B1 (ko) | 2004-07-26 | 2013-01-16 | 제넨테크, 인크. | 간세포 성장 인자 활성화를 조정하기 위한 조성물 및 방법 |
CN101490088B (zh) | 2006-06-22 | 2015-04-08 | 健泰科生物技术公司 | 用于靶向hepsin的方法和组合物 |
US20100061996A1 (en) * | 2006-06-22 | 2010-03-11 | Genentech, Inc. | Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
CA2778481A1 (en) * | 2009-10-22 | 2011-04-28 | Genentech, Inc. | Anti-hepsin antibodies and methods using same |
-
2007
- 2007-06-20 CN CN200780027496.XA patent/CN101490088B/zh not_active Expired - Fee Related
- 2007-06-20 MY MYPI20085215 patent/MY150643A/en unknown
- 2007-06-20 KR KR1020097001309A patent/KR101410195B1/ko not_active IP Right Cessation
- 2007-06-20 EP EP07798834A patent/EP2044124A2/en not_active Withdrawn
- 2007-06-20 BR BRPI0712273A patent/BRPI0712273A8/pt not_active Application Discontinuation
- 2007-06-20 US US12/306,208 patent/US8124352B2/en not_active Expired - Fee Related
- 2007-06-20 AU AU2007260950A patent/AU2007260950B2/en not_active Ceased
- 2007-06-20 MX MX2008015882A patent/MX2008015882A/es active IP Right Grant
- 2007-06-20 WO PCT/US2007/071688 patent/WO2007149932A2/en active Application Filing
- 2007-06-20 NZ NZ573178A patent/NZ573178A/en not_active IP Right Cessation
- 2007-06-20 JP JP2009516706A patent/JP2009540835A/ja active Pending
- 2007-06-20 CA CA002656168A patent/CA2656168A1/en not_active Abandoned
- 2007-06-20 ZA ZA200810225A patent/ZA200810225B/xx unknown
- 2007-06-20 RU RU2009101813/10A patent/RU2009101813A/ru not_active Application Discontinuation
-
2008
- 2008-11-27 IL IL195561A patent/IL195561A/en active IP Right Grant
-
2009
- 2009-01-21 NO NO20090333A patent/NO20090333L/no not_active Application Discontinuation
-
2012
- 2012-01-20 US US13/355,243 patent/US8383123B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
RU2009101813A (ru) | 2010-07-27 |
ZA200810225B (en) | 2010-03-31 |
BRPI0712273A8 (pt) | 2019-01-22 |
KR101410195B1 (ko) | 2014-06-19 |
AU2007260950A8 (en) | 2009-01-22 |
NZ573178A (en) | 2012-02-24 |
IL195561A (en) | 2013-04-30 |
IL195561A0 (en) | 2011-08-01 |
US8383123B2 (en) | 2013-02-26 |
NO20090333L (no) | 2009-03-23 |
AU2007260950B2 (en) | 2011-09-15 |
CN101490088B (zh) | 2015-04-08 |
MY150643A (en) | 2014-02-14 |
WO2007149932A3 (en) | 2008-05-02 |
AU2007260950A1 (en) | 2007-12-27 |
US20100021474A1 (en) | 2010-01-28 |
MX2008015882A (es) | 2009-01-12 |
KR20090029276A (ko) | 2009-03-20 |
EP2044124A2 (en) | 2009-04-08 |
WO2007149932A2 (en) | 2007-12-27 |
JP2009540835A (ja) | 2009-11-26 |
CA2656168A1 (en) | 2007-12-27 |
US8124352B2 (en) | 2012-02-28 |
US20120141374A1 (en) | 2012-06-07 |
CN101490088A (zh) | 2009-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0712273A2 (pt) | Anticorpos isolados, polipeptídeos imunoglobulinas, anticorpo hepsina, molécula de ácido nucléico, célula hospedeira, linhagem celular, métodos para produzir o anticorpo, para diagnosticar a presença de hepsina, tratar uma doença, para monitorar a doença residual, para detectar o estado da doença, para diagnosticar uma disfunção, composição, arranjo ou chip de proteína e kit | |
BR112014010161A2 (pt) | anticorpo monoclonal antiproteína de ligação ao dna tar de 43 kda (tdp-43) e seus método de preparação e uso no tratamento de proteinopatia tdp-43, bem como composições, polinucleotídeo, método in vitro e kit para diagnosticar proteinopatia tdp-43 | |
PH12016500658A1 (en) | Human anti-alpha-synuclein autoantibodies | |
BR112012007365A2 (pt) | proteínas de ligação à il-1 | |
BRPI0519775A2 (pt) | proteÍna isolada de ligaÇço a antÍgeno, polinucleotÍdeo isolado, plasmÍdio e cÉlula isolada e composiÇço farmacÊutica | |
AR067199A1 (es) | Proteinas de union a antigenos que se unen a par-2 | |
WO2010009987A3 (en) | Diagnostic antibody assay | |
EA200801621A1 (ru) | Антитела, направленные на her-3, и их применение | |
CY1115935T1 (el) | Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
BR112015014751A2 (pt) | anticorpos anti-tau humanos | |
ATE443161T1 (de) | Mittel und verfahren für den nachweis von methylierter dna | |
ATE283289T1 (de) | Monoklonale antikörper, antigene sowie diagnose und therapie von bösartigen krankheiten | |
JP2013116897A5 (pt) | ||
WO2008136848A3 (en) | Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease | |
EP2332988A3 (en) | Monoclonal antibodies and methods for their use in the detection of cervical disease | |
KR102311590B1 (ko) | 신장 질환 및 치주 질환의 검출 및 진단을 위한 방법 및 조성물 | |
ATE474857T1 (de) | Antikörper gegen ein epitop auf agr2, assays und hybridome | |
WO2007111875A3 (en) | Methods for diagnosing and treating kidney and colorectal cancer | |
BR112013021056A2 (pt) | anticorpo monoclonal, linhagem de células de hibridoma, kit para diagnóstico, métodos para a produção de um anticorpo monoclonal e de um agente de ligação, agente de ligação sequência de aminoácidos purificada, método para a obtenção de uma sequência do ácido nucleico codificante, molécula do ácido nucleico isolado codificante, vetor, célula hospedeira isolada, proteína de fusão, método de triagem para a presença de uma doença, de uma condição, métodos de diagnóstico de um indivíduo, de prognóstico para um indivíduo, e de monitoramento de um indivúdo, e, método para detecção da presença ou ausência de um câncer cervical | |
EP2083018A3 (en) | Compositions and methods relating to STOP-1 | |
ES2226823T3 (es) | Isoforma c de la tenascina como marcador de neoplasias. | |
DE502004008729D1 (de) | Gegen das Prothrombin-Fragment F1+2 gerichtete Antikörper, ihre Herstellung und Verwendung | |
RU2011109883A (ru) | Способ диагностики рака мочевого пузыря с помощью онкомаркера kifc1 (варианты) и набор для его осуществления | |
AU2016100899A4 (en) | Method of determining the presence and/or amount of osteopontin, a kit and their use for diagnosis and prognosis | |
MX360580B (es) | Autoanticuerpos humanos anti-alfa-sinucleina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |